dr. george demetri discusses regorafenib for patients with gist trial results
Published 12 years ago • 983 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
1:49
dr. george demetri describes the mechanism of action of regorafenib in gist
-
1:21
dr. george demetri explains the side effects associated with regorafenib
-
9:39
george d. demetri: grid trial
-
0:42
dr. keedy on regorafenib for the treatment of gist
-
5:31
practical advice for using regorafenib
-
11:24
managing toxicities associated with regorafenib
-
1:02
regorafenib as a treatment for gist (gastrointestinal stromal tumour) patients
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
33:55
updates rectal cancer | 2023 best of gi cancer conference
-
3:24
rachel's story | 20 years living with incurable cancer (gist sarcoma)
-
39:00
overview of nets: how we find, classify, and treat them; george fisher, md, phd, stanford
-
2:38
regorafenib lengthens suvival in colorectal cancer with kras mutation
-
10:02
role of the multikinase inhibitor regorafenib in metastatic colorectal cancer
-
1:30
dr. nancy l. lewis discusses the correct trial for regorafenib in metastatic colorectal cancer
-
7:35
use of regorafenib in refractory mcrc
-
1:04
dr. randall holcombe discusses regorafenib for metastatic colorectal cancer
-
3:53
regorafenib in colorectal cancer: optimizing the dose
-
8:14
optimizing treatment with regorafenib in metastic colorectal cancer
-
0:52
dr. george demetri on being named a giant of cancer care
-
9:34
regorafenib in colorectal cancer
-
1:29
dr. demetri on larotrectinib in trk-fusion gi cancers
-
3:32
dr. george demetri on blood test for cancer mutations | dana-farber cancer institute